Identification of an efflux pump gene, pmrA, associated with fluoroquinolone resistance in Streptococcus pneumoniae.
about
A balancing act: efflux/influx in mycobacterial drug resistanceGenome sequencing of linezolid-resistant Streptococcus pneumoniae mutants reveals novel mechanisms of resistanceBacterial Multidrug Efflux Pumps: Much More Than Antibiotic Resistance DeterminantsMolecular properties of bacterial multidrug transportersFunctionally cloned pdrM from Streptococcus pneumoniae encodes a Na(+) coupled multidrug efflux pumpMolecular Analysis of Rising Fluoroquinolone Resistance in Belgian Non-Invasive Streptococcus pneumoniae Isolates (1995-2014)Xenobiotic efflux in bacteria and fungi: a genomics updateDeciphering the distance to antibiotic resistance for the pneumococcus using genome sequencing dataActivities of clinafloxacin, gatifloxacin, gemifloxacin, and trovafloxacin against recent clinical isolates of levofloxacin-resistant Streptococcus pneumoniae.Fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae: contributions of type II topoisomerase mutations and efflux to levels of resistance.Overexpression of patA and patB, which encode ABC transporters, is associated with fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniaeHigh genetic diversity of ciprofloxacin-nonsusceptible isolates of Streptococcus pneumoniae in Poland.Antimicrobial susceptibility of Streptococcus pneumoniae in eight European countries from 2001 to 2003.Molecular detection of antimicrobial resistanceActivity of gemifloxacin against penicillin- and ciprofloxacin-resistant Streptococcus pneumoniae displaying topoisomerase- and efflux-mediated resistance mechanisms.Prevalence of gyrA, gyrB, parC, and parE mutations in clinical isolates of Streptococcus pneumoniae with decreased susceptibilities to different fluoroquinolones and originating from Worldwide Surveillance Studies during the 1997-1998 respiratory seFluoroquinolone resistance associated with target mutations and active efflux in oropharyngeal colonizing isolates of viridans group streptococci.Benchmarking the in vitro activities of moxifloxacin and comparator agents against recent respiratory isolates from 377 medical centers throughout the United States.Activities of newer fluoroquinolones against ciprofloxacin-resistant Streptococcus pneumoniae.Efflux-mediated resistance to fluoroquinolones in gram-positive bacteria and the mycobacteriaAntimicrobial activities of garenoxacin (BMS 284756) against Asia-Pacific region clinical isolates from the SENTRY program, 1999 to 2001.Quinolone efflux pumps play a central role in emergence of fluoroquinolone resistance in Streptococcus pneumoniae.Nonmolecular test for detection of low-level resistance to fluoroquinolones in Streptococcus pneumoniae.Antimicrobial susceptibility breakpoints and first-step parC mutations in Streptococcus pneumoniae: redefining fluoroquinolone resistance.Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteriaEfflux pump Lde is associated with fluoroquinolone resistance in Listeria monocytogenesGenetic relatedness of levofloxacin-nonsusceptible Streptococcus pneumoniae isolates from North America.Fluoroquinolone efflux in Streptococcus suis is mediated by SatAB and not by SmrAFirst characterization of fluoroquinolone resistance in Streptococcus suis.Mechanisms of drug resistance: quinolone resistance.Whole Genome Sequencing of 39 Invasive Streptococcus pneumoniae Sequence Type 199 Isolates Revealed Switches from Serotype 19A to 15BActivities of different fluoroquinolones against Bacillus anthracis mutants selected in vitro and harboring topoisomerase mutations.Distribution and physiology of ABC-type transporters contributing to multidrug resistance in bacteria.Genomic characterization of ciprofloxacin resistance in a laboratory-derived mutant and a clinical isolate of Streptococcus pneumoniae.Levofloxacin-resistant invasive Streptococcus pneumoniae in the United States: evidence for clonal spread and the impact of conjugate pneumococcal vaccineMutant selection window in levofloxacin and moxifloxacin treatments of experimental pneumococcal pneumonia in a rabbit model of human therapy.Topoisomerase Inhibitors: Fluoroquinolone Mechanisms of Action and Resistance.Fluoroquinolone Resistance among Clonal Complex 1 Group B Streptococcus Strains.Fluoroquinolone resistance is a poor surrogate marker for type II topoisomerase mutations in clinical isolates of Streptococcus pneumoniae.Association of alterations in ParC and GyrA proteins with resistance of clinical isolates of Enterococcus faecium to nine different fluoroquinolones.
P2860
Q24644870-26C05F64-90F5-4133-B53F-2CAED6F0E74AQ24655140-11F92C46-24E3-40FC-B6C5-4FCC0C72351BQ28073636-F1F64BED-49A5-4AD4-92FC-DD1D189ABF40Q28139376-38858B45-C47C-44F9-8507-E39DC46C9652Q28488994-47EB663F-B4DF-45DB-91B5-9DD960E29618Q28552446-FF4162F6-46F3-4C0E-A68C-DBD3BF85D5EEQ28834633-E5E4CD87-514F-41BA-875A-0AECACBDC7C5Q31162440-953D1528-7303-4B84-A009-76FF7E67F293Q33593776-4EA6517D-29AF-4B19-B715-0C5505E6C39FQ33594174-DE1DEEC1-E7CF-4EC0-B72D-9EA961DC6C31Q33715260-7B8EF495-C5D0-486A-8909-16529BC330D1Q33770218-02AF7AEF-E1EE-4D76-A39E-FF2A82B33B6EQ33883600-772E0F12-106B-4FD6-9778-7BD24FD61180Q33975793-B3DC7694-157E-461D-A3CD-8A9094B7A281Q33978324-AC8AAE37-BB17-4215-9F5C-618F30457BF8Q33978849-7023BC55-EC16-4383-8D00-F5F75CD28AA7Q33980313-F2402B41-52C7-4CF5-9082-3F3D00598BDEQ33980689-7E616A4D-3A20-430B-93B2-D76DA0ECC220Q33982211-EEB87A2A-C0E0-4001-89DC-E96F9D9E3429Q34035762-096F5569-143D-4A8D-9B87-95A39DDCE3E9Q34139244-C713BB55-A782-48D8-90C0-732CAB66BFFBQ34301541-F0159F8B-9D65-4C0A-9E91-906363C2E5C9Q34352053-F245E161-94E0-4910-AC52-6507FB30381FQ34502866-6486997F-F78F-41BD-8078-707A5104461AQ34647294-18A335B4-D45C-4936-8823-0FC4D9CDF6D4Q34820625-CA320D32-88BA-41AD-85C5-E1C33F141E87Q35026714-EFBDE7D0-02BA-46A1-98B7-8B0FB716F0DFQ35598367-BA1B805F-AF4C-40FC-8420-D212CF26A2FFQ35636018-3DA73C39-BA30-4A90-B920-62B24FC0A428Q36225422-9C383F01-2585-47F4-ABB0-C14CDF3DF10DQ36238637-D5542D72-7ACC-4116-BF3C-341D554F99F3Q36669771-52CAB631-CE4B-47A2-B670-12D0AF2C41C6Q36931422-5C09FAC5-AD4C-49ED-B953-0AD45A724176Q37263914-4DC085BE-A7AD-4549-B76F-5F3D6DB26B1BQ37489226-755BF537-39FF-4732-B945-53FB88CB9F09Q37733449-938CCD35-9B71-4055-9590-C33DBA77B735Q38906198-ECECD46D-E89D-4326-88D2-EB7E9475AAE5Q39455259-66750A0F-6569-40A6-B8FC-2ED087C12CD7Q39465570-276AA2CE-C1CD-4454-AEF1-BECF9868A795Q39472007-8315206D-81FB-409C-A4D6-1042C11C1506
P2860
Identification of an efflux pump gene, pmrA, associated with fluoroquinolone resistance in Streptococcus pneumoniae.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Identification of an efflux pu ...... e in Streptococcus pneumoniae.
@en
Identification of an efflux pu ...... e in Streptococcus pneumoniae.
@nl
type
label
Identification of an efflux pu ...... e in Streptococcus pneumoniae.
@en
Identification of an efflux pu ...... e in Streptococcus pneumoniae.
@nl
prefLabel
Identification of an efflux pu ...... e in Streptococcus pneumoniae.
@en
Identification of an efflux pu ...... e in Streptococcus pneumoniae.
@nl
P2093
P2860
P356
P1476
Identification of an efflux pu ...... ce in Streptococcus pneumoniae
@en
P2093
P2860
P304
P356
10.1128/AAC.43.1.187
P407
P577
1999-01-01T00:00:00Z